Search Results - ccl8

1 Results

Sort By:

Anti-CCL8 Antibodies for COVID-19 and Other Immune Related Conditions

Reference #: 01487 The University of South Carolina is offering licensing opportunities for Anti-CCL8 Antibodies for COVID-19 and Other Immune Related Conditions Background: CCL8 (MCP-2) is a chemo attractive cytokine that is involved in the pathogenesis of various pathologies including cancer, autoimmune disorders, graft versus host disease and...

Published: 9/16/2024 | Inventor(s): Hippokratis Kiaris, Asieh Naderi, Ioulia Chatzistamou

Keywords(s): ARDS, CCL8, COVID-19

Category(s): Health Sciences, Biomedical and Life Sciences